Drugs / Systane Hydration PF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04837807 | Aug → Nov 2021 | dry eye syndrome | University of Alabama at Birmingham | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2023-03-01 | Alcon Research | Results Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023 alcon.com ↗
The research findings on SYSTANE HYDRATION PF highlight the product’s Hydroboost technology to restore moisture and serve as a protectant against irritation and provide relief from dry eye symptoms. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2023-03-01 | Alcon Research | Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023 alcon.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Systane Hydration PF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04837807 ↗ |
| Route | Topical | “Subjects randomized to this group will apply the unit-dose version of Systane Hydration PF to determine if it helps alleviate symptoms associated with digital eye strain.” NCT04837807 ↗ |